Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Genialis
Genialis is a precision oncology company that leverages advanced AI and deep biological expertise to develop clinically actionable RNA biomarkers and therapeutic intelligence solutions. Their…
Genialis
Genialis is a precision oncology company that leverages advanced AI and deep biological expertise to develop clinically actionable RNA biomarkers and therapeutic intelligence solutions. Their…
TL;DR
Sector: Precision oncology / Biotechnology
Founded: 2015
Core product: AI/ML-driven RNA biomarker discovery platforms (Genialis Supermodel, ResponderID, krasID)
Business model: SaaS and services for pharma and diagnostics partners
Recent financing: Series A (announced Mar 29, 2023) raising >$13M
Company Overview
Problem Domain
Precision oncology biomarker discovery and patient-response prediction for clinical trials and drug development.
Founded
2015
Industry
Biotechnology
Tech Stack
Funding Track Record
2300000
Seed round co-led by Redalpine and First Star Ventures with participation from Pikas and angels.
13000000
Series A announced co-led by Taiwania Capital and Debiopharm Innovation Fund (reported as more than $13M).
Investor Signal
“Debiopharm Innovation Fund and Taiwania Capital Management Corporation are lead/co-lead investors; participation from Redalpine, First Star Ventures, Pikas, and P5 Health Ventures.”
